Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

RayzeBio, Inc. Common Stock

RYZB•NASDAQ
Healthcare
Biotechnology
$62.49
$0.01(0.02%)
U.S. Market opens in 14h 28m

RayzeBio, Inc. Common Stock (RYZB) Stock Overview

Explore RayzeBio, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.8B
P/E Ratio-35.73
EPS (TTM)$-1.08
ROE0.83%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$305.20

RYZB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RayzeBio, Inc. Common Stock (RYZB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $305.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.73 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
104.42%
6-Month Change
218.50%
Year-to-Date (YTD) Change
0.87%
1-Year Change
160.38%
3-Year Change
160.38%
5-Year Change
160.38%
All-Time (Max) Change
160.38%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

880 Employees
IPO DateSep 15, 2023
CountryUS

Frequently Asked Questions